Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06593418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Radioablation for VT

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Sep 2026 to Jan 2028
    • Start date: Sep 2025 to Jul 2026
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v5
  2. Start date: Feb 2025 to Sep 2025
    • Primary and study completion dates: Aug 2026 to Sep 2026
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 21, 2024 to Feb 2025
    • Site details revised
    v3
  4. Start date: Oct 1, 2024 to Nov 21, 2024
    • Site contact updated
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this interventional study is to determine the minimum dose necessary for successful cardiac radioablation of refractory ventricular tachycardia (VT) and to study the utility of target volume definition using Delayed Enhancement Cardiac MRI (DE-CMR) .
Trial Details
NCT Number NCT06593418
Lead Sponsor Corewell Health East
Conditions
(from sponsor)		 Ventricular Tachycardia, Myocardial Infarction
Related terms Myocardial Infarction, Tachycardia, Ventricular
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov